Lexicon Pharmaceuticals reported $150K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Akebia Therapeutics AKBA:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
AstraZeneca AZN:LN 387M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Clovis Oncology CLVS:US $ 0.14M 0M
Coherus Biosciences CHRS:US $ 0.01M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
Halozyme Therapeutics HALO:US $ 0.14M 0M
Illumina ILMN:US $ 2M 0M
Insmed INSM:US $ 1.2M 6K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Ironwood Pharmaceuticals IRWD:US $ 0.15M 0M
Macrogenics MGNX:US $ 0.62M 0M
Mannkind MNKD:US $ 2.57M 0.05M
Moderna Inc MRNA:US 39.2K 800
Novartis NOVN:VX SF 890M 11M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regulus Therapeutics RGLS:US $ 0.02M 0.13M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M